Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs185229225
rs185229225
0.700 GeneticVariation GWASCAT Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence. 27047539

2016

dbSNP: rs113488022
rs113488022
0.010 GeneticVariation BEFREE Germ line and somatic mutations of BRAF V599E in ovarian carcinoma. 17309670

2007

dbSNP: rs121913377
rs121913377
0.010 GeneticVariation BEFREE Germ line and somatic mutations of BRAF V599E in ovarian carcinoma. 17309670

2007

dbSNP: rs1799950
rs1799950
0.010 GeneticVariation BEFREE Further characterisation of rs1799950 is now warranted in relation to chemosensitivity and susceptibility to developing ovarian carcinoma. 29298688

2018

dbSNP: rs80358721
rs80358721
0.010 GeneticVariation BEFREE Three ovarian cancer cell lines (PEO1, PEO4, and PEO6) were derived from a BRCA2 mutation [5193C>G (Y1655X)] carrier with ovarian carcinoma with acquired cisplatin resistance and a secondary BRCA2 mutation [5193C>T (Y1655Y)] that canceled the inherited mutation. 19654294

2009

dbSNP: rs121964872
rs121964872
0.700 GeneticVariation UNIPROT

dbSNP: rs495139
rs495139
0.020 GeneticVariation BEFREE Biomarkers that distinguish ovarian carcinoma types are few, and TYMS rs495139 may provide a novel clue to type etiology. 20570913

2010

dbSNP: rs495139
rs495139
0.020 GeneticVariation BEFREE In expression quantitative trait locus (eQTL) analysis, the rs495139 allele was positively associated with ENOSF1 mRNA expression in normal tissues of the gastrointestinal system, particularly esophageal mucosa (<i>r</i> = 0.51, <i>p</i> = 1.7 × 10<sup>-28</sup>), and nonsignificantly in five MOC tumors. 30134598

2018

dbSNP: rs238406
rs238406
0.010 GeneticVariation BEFREE The R156R (C to A, rs238406) polymorphism of ERCC2 gene was investigated by the PCR-RFLP technique in 400 patients with ovarian carcinoma and 400 age- and sex matched non-cancer controls. 27888704

2017

dbSNP: rs1271572
rs1271572
0.020 GeneticVariation BEFREE Compared to homozygous common allele carriers, homozygous carriers of variant alleles for rs1271572 [odds ratio (OR) = 1.79, 95% confidence interval (CI):1.15-2.79, p global = 0.01] and rs1256030 [OR = 1.67, CI: 1.08-2.59, p global = 0.04], and women with haplotypes, including variant alleles of rs1271572, rs1256030, and rs1256031 SNPs [OR = 1.75, CI: 1.17-2.63, p global = 0.007], had significantly increased risk of ovarian carcinoma. 18704709

2009

dbSNP: rs1271572
rs1271572
0.020 GeneticVariation BEFREE Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium. 21673961

2011

dbSNP: rs1256030
rs1256030
0.010 GeneticVariation BEFREE Compared to homozygous common allele carriers, homozygous carriers of variant alleles for rs1271572 [odds ratio (OR) = 1.79, 95% confidence interval (CI):1.15-2.79, p global = 0.01] and rs1256030 [OR = 1.67, CI: 1.08-2.59, p global = 0.04], and women with haplotypes, including variant alleles of rs1271572, rs1256030, and rs1256031 SNPs [OR = 1.75, CI: 1.17-2.63, p global = 0.007], had significantly increased risk of ovarian carcinoma. 18704709

2009

dbSNP: rs1256031
rs1256031
0.010 GeneticVariation BEFREE Compared to homozygous common allele carriers, homozygous carriers of variant alleles for rs1271572 [odds ratio (OR) = 1.79, 95% confidence interval (CI):1.15-2.79, p global = 0.01] and rs1256030 [OR = 1.67, CI: 1.08-2.59, p global = 0.04], and women with haplotypes, including variant alleles of rs1271572, rs1256030, and rs1256031 SNPs [OR = 1.75, CI: 1.17-2.63, p global = 0.007], had significantly increased risk of ovarian carcinoma. 18704709

2009

dbSNP: rs861539
rs861539
0.010 GeneticVariation BEFREE The obtained results indicate that XRCC2 Arg188His and XRCC3 Thr241Met polymorphisms may be positively associated with the incidence of ovarian carcinoma in the population of Polish women. 26801223

2016

dbSNP: rs2073495
rs2073495
LTF
0.010 GeneticVariation BEFREE In this study, we determined the distribution of LTF gene polymorphisms (rs1126477, rs1126478, rs2073495, and rs9110) in the Chinese Han population and investigated whether these polymorphisms were associated with increased risk of ovarian carcinoma in the Chinese. 21937479

2011

dbSNP: rs9110
rs9110
LTF
0.010 GeneticVariation BEFREE In this study, we determined the distribution of LTF gene polymorphisms (rs1126477, rs1126478, rs2073495, and rs9110) in the Chinese Han population and investigated whether these polymorphisms were associated with increased risk of ovarian carcinoma in the Chinese. 21937479

2011

dbSNP: rs121434596
rs121434596
0.010 GeneticVariation BEFREE NRAS mutation in codon 13 (G13D, p.Gly13Asp; nucleotide: c.38G>A) was found in one patient, a woman with low-grade serous ovarian carcinoma. 29682098

2018

dbSNP: rs5275
rs5275
0.010 GeneticVariation BEFREE The association of PTGS2 rs5275 with nonserous ovarian carcinoma and possible effect modification by NSAID use needs further validation, preferably in prospective studies. 20559705

2010

dbSNP: rs121913322
rs121913322
0.700 GeneticVariation UNIPROT

dbSNP: rs25487
rs25487
0.010 GeneticVariation BEFREE Impact of RAD51 G135C and XRCC1 Arg399Gln polymorphisms on ovarian carcinoma risk in Serbian women. 26406958

2015

dbSNP: rs3218536
rs3218536
0.010 GeneticVariation BEFREE The obtained results indicate that XRCC2 Arg188His and XRCC3 Thr241Met polymorphisms may be positively associated with the incidence of ovarian carcinoma in the population of Polish women. 26801223

2016